| Drug Name: | Ergotamine (113-15-5) |
|---|---|
| PubChem ID: | 9787 |
| SMILES: | C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C.C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O |
| InchiKey: | CJMJLDQKTOJACI-BGQAIRJTSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 1313.43 |
| LogP | : | 1.859 |
| Ring Count | : | 6 |
| Hydrogen Bond Acceptor Count | : | 16 |
| Hydrogen Bond Donor Count | : | 10 |
| Total Polar Surface Area | : | 351.48 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Indinavir (150378-17-9) | Ergotism | Synergistic | Protease inhibitors reduce the metabolism of ergotamine by inhibiting the cytochrome P450 isoenzyme CYP3A4 to varying degrees. Therefore ergotamine levels are increased, which | Ergotism related to concurrent administration of ergotamine tartrate and indinavir |
| Methysergide (361-37-5) | Ischaemia | Synergistic | Cluster headaches are associated with abnormal dilatation of the carotid arteries, which can be constricted by ergot derivatives. In the cases cited it would seem that combined vasoconstrictor effects caused arterial spasm elsewhere in the body | Arterial complications of migraine treatment with methysergide and parenteral ergotamine |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|---|---|
| Grapefruit Juice | Gangrene | Interactions between grapefruit juice and cardiovascular drugs |
| Grapefruit Juice | Stroke | Interactions between grapefruit juice and cardiovascular drugs |
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category